The National Institute for Health and Care Excellence has issued guidance requiring women diagnosed with premenstrual syndrome to receive annual health check-ups through the NHS. The watchdog confirmed the new recommendation applies to all women with moderate to severe symptoms. NICE published the updated guidance this month following a review of existing care pathways.
What the New Guidelines Require
NICE now advises that women with a confirmed PMOS diagnosis should be offered a yearly review with their GP or a specialist. The check-up must include symptom tracking, medication review, and mental health screening. Local clinical commissioning groups have until April to implement the new requirements across England.
The guidance document outlines that these annual reviews should assess whether current treatment plans remain effective. Doctors are also instructed to discuss lifestyle factors including diet, exercise, and stress management during each visit. Any woman experiencing worsening symptoms between annual reviews should be able to request an earlier appointment without delay.
Who Qualifies for the Annual Check
The requirement covers women experiencing moderate to severe premenstrual syndrome that significantly impacts daily functioning. NICE estimates that around one in 20 women of reproductive age has symptoms severe enough to warrant diagnosis and treatment. The guidelines specify that diagnosis must be confirmed through prospective symptom tracking over at least two menstrual cycles.
Why This Change Matters
Campaign groups have long argued that women with PMOS face barriers accessing consistent care. Many report difficulty obtaining referrals to specialist services or experience frequent changes in treatment without proper follow-up. The new annual check-up mandate aims to address these inconsistencies by establishing a minimum standard of care across all NHS trusts.
Dr Sarah Matthews, a consultant gynaecologist at University College London Hospitals, welcomed the move. She noted that regular monitoring allows clinicians to adjust treatment before symptoms spiral. The guidelines also emphasise the need for better documentation of symptoms to help researchers understand the condition more thoroughly.
Implementation Challenges Ahead
GP practices across England are already under significant pressure from appointment backlogs and staffing shortages. The Royal College of General Practitioners has expressed concern about adding further obligations without corresponding resources. The Department of Health and Social Care has not yet confirmed whether additional funding will accompany the new requirement.
Patient advocates worry that implementation may prove uneven across different regions. Women in areas with fewer specialist services could face longer waits for their annual review. NICE has urged commissioners to prioritise training for primary care staff to ensure the guidelines translate into consistent patient experience.
What Happens Next
NHS England will publish implementation resources for GP practices by the end of the current quarter. The health service has also committed to updating its online information pages to reflect the new entitlement. Women currently receiving treatment for PMOS should receive notification from their GP surgery about their upcoming annual review schedule.
Monitoring data will be collected through the GP rewards scheme to track uptake and identify areas lagging behind the national average. NICE plans to review the guideline again in three years to assess whether the annual check-up requirement has improved patient outcomes. Those seeking support can contact the National Association for Premenstrual Syndrome for resources and community connections.
See Also
- Zimbabwe Border Police Halt Migrant Buses at Beitbridge
- Kebbi Court Adjourns Nurse Trial Over Alleged Deaths of Two Children
